Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays. OH&RM [Internet]. 13 déc. 2023 [cité 31 juill. 2026];:77. Disponible sur: https://www.journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/657